BENZODIAZEPINE ENZYME IMMUNOASSAY— 510(k) K930529

Name: FDA 510(k) clearance K930529
Creator: U.S. Food and Drug Administration
Published: 1993-08-05

Substantially Equivalent

Diagnostic Reagents, Inc.

FDA 510(k) clearance K930529 for BENZODIAZEPINE ENZYME IMMUNOASSAY, Substantially Equivalent on 1993-08-05. Applicant: Diagnostic Reagents, Inc.. Device class: 2.

Clearance details

Applicant: Diagnostic Reagents, Inc.
Product code: Code JXM
Device class: Class 2
Regulation: 21 CFR 862.3170
Advisory panel: Clinical Toxicology
Date received: 1993-02-02
Decision date: 1993-08-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mountain View, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JXM

view all

K243498 — Alinity c Benzodiazepines Reagent Kit2024-12-11
K221765 — ONLINE DAT Benzodiazepines II2022-12-23
K190968 — CEDIA Benzodiazepine Assay2019-12-09
K173963 — DRI Benzodiazepine Assay2018-02-21
K163590 — Psychemedics Microplate EIA for Benzodiazepines in Hair2017-09-15

More clearances from Diagnostic Reagents, Inc.

view all

K983268 — MODIFICATION OF TRICYCLIC SERUM TOX EIA ASSAY1998-11-18
K983812 — NAPA EIA ASSAY1998-11-16
K983323 — DIGOXIN IMMUNOASSAY1998-11-12
K983280 — VANCOMYCIN EIA ASSAY1998-11-06
K983159 — DRUGS OF ABUSE URINE CALIBRATORS AND CONTROLS1998-11-05

Data sourced from openFDA. This site is unofficial and independent of the FDA.